Report of foreign issuer [Rules 13a-16 and 15d-16]

Consolidated Statements of Cash Flows

v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net loss $ (13,054) $ (25,983)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 10,771 12,266
Stock-based compensation 6,213 8,649
Foreign currency transaction loss (gain) (2,288) 2,054
Share in net (profits) losses of associated companies 1,668 2,031
Unrealized Gain (Loss) on Investments 180 1,747
Acquisitions 506 511
Deferred income taxes, net and uncertain tax positions 123 183
Other non-cash items, net 21 493
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net (4,772) 15,461
Inventories 9,945 897
Other current assets and prepaid expenses (2,077) 1,872
Other non-current assets 1,486 3,148
Accounts payable (9,329) (9,507)
Other current liabilities (80) (115)
Deferred revenues 6,127 (2,202)
Other non-current liabilities (898) (4,165)
Net cash provided by (used in) operating activities 4,542 7,340
Cash flows from investing activities    
Purchase of property and equipment (3,753) (2,329)
Investments in short-term bank deposits (40,000) (10,000)
Proceeds from sale of equity method investment 40,500 20,000
Purchase of intangible assets (485) (658)
Other investing activities (20) (120)
Payments to Acquire Long-Term Investments (330) (4,993)
Net cash used in investing activities (4,088) 1,900
Cash flows from financing activities    
Proceeds from exercise of stock options 0 149
Payment of contingent consideration (100) (430)
Other financing activities 300 465
Net cash provided by (used in) financing activities 200 184
Effect of exchange rate changes on cash, cash equivalents and restricted cash (841) (925)
Net change in cash, cash equivalents and restricted cash (187) 8,499
Cash, cash equivalents and restricted cash, beginning of year 71,076 82,864
Cash, cash equivalents and restricted cash, end of year 70,889 91,363
Non-cash investing and financing activities:    
Transfer of inventories to fixed assets 1,701 545
Transfer of fixed assets to inventories 0 4,692
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 70,061 91,089
Restricted cash included in other current assets 828 274
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total $ 70,889 $ 91,363